Skip to content

Clinical trials

Myeloproliferative Disorders trials in Croatia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myeloproliferative Disorders Country / region: Croatia Clear all

4 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20191
20201
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status2
Active, not recruiting1
Completed1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie1
European Organisation for Research and Treatment of Cancer - EORTC1
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS1
Taiga Biotechnologies, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myeloproliferative Disorders4
Leukemia2
Leukemia, Myelomonocytic, Chronic2
Primary Myelofibrosis2
Anemia, Refractory1
Anemia, Refractory, with Excess of Blasts1
Bone Marrow Neoplasms1
Leukemia, Myeloid, Acute1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative1
Myelodysplastic Syndromes1

Trials

Showing 1 to 4 of 4. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.